atrial natriuretic peptide (Beijing SL Pharmaceutical)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameatrial natriuretic peptide (Beijing SL Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sl Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A